Actelion (XSWX:ATLN) Marketable Securities : CHF0 Mil (As of Mar. 2017)

View and export this data going back to 2000. Start your Free Trial

What is Actelion Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Actelion's Marketable Securities for the quarter that ended in Mar. 2017 was CHF0 Mil.

Actelion Marketable Securities Historical Data

The historical data trend for Actelion's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actelion Marketable Securities Chart

Actelion Annual Data

Trend

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Dec16

Marketable Securities

Get a 7-Day Free Trial

100.75

250.75

Actelion Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Marketable Securities	Get a 7-Day Free Trial															-	-	-	-	-

Actelion Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Actelion (XSWX:ATLN) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Actelion Marketable Securities Related Terms

Thank you for viewing the detailed overview of Actelion's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Actelion (XSWX:ATLN) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actelion Ltd (XSWX:ATLN) » Definitions » Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.actelion.com

Actelion is a Swiss biopharmaceutical firm with several products on the market, largely focused on pulmonary arterial hypertension: Tracleer, Opsumit, Uptravi, Ventavis, and Veletri treat various stages of the disease via different methods of administration. Zavesca is a second-line option for Gaucher disease, and Valchlor treats a rare form of blood cancer. Actelion has created a global commercial infrastructure for its approved orphan drugs and has supplemented its internal pipeline through in-licensing and acquisitions.

Actelion (XSWX:ATLN) Headlines

No Headlines